Manu R. Pandey

Hematology
800 NE 10th St
Oklahoma City, OK 73104

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Comparative Risk of Adverse Cardiovascular Outcomes With Zanubrutinib Versus Ibrutinib in B-Cell Malignancies: A Large Real-World Propensity-Matched Analysis.

Comparative Risk of Adverse Cardiovascular Outcomes With Zanubrutinib Versus Ibrutinib in B-Cell Malignancies: A Large Real-World Propensity-Matched Analysis.

Journal: The American journal of cardiology
Published: February 26, 2026

Optimizing Natural Killer Cellular Therapy in Acute Myeloid Leukemia.

Optimizing Natural Killer Cellular Therapy in Acute Myeloid Leukemia.

Journal: American journal of clinical oncology
Published: December 03, 2025

The Bottom Line: Donor Age Over HLA Mis-Match? Picking a Mismatched Donor in the Era of Post-Transplant Cyclophosphamide.

The Bottom Line: Donor Age Over HLA Mis-Match? Picking a Mismatched Donor in the Era of Post-Transplant Cyclophosphamide.

Journal: Transplantation and cellular therapy
Published: August 28, 2025

The role of interim bone marrow assessments in acute myeloid leukemia - A systematic review and meta-analysis.

The role of interim bone marrow assessments in acute myeloid leukemia - A systematic review and meta-analysis.

Journal: Leukemia research
Published: August 02, 2025

Physician Advocacy for Hematopoietic Cell Transplantation and Cell Therapy: Overcoming Challenges to Reduce Disparities and Improve Outcomes for Patients.

Physician Advocacy for Hematopoietic Cell Transplantation and Cell Therapy: Overcoming Challenges to Reduce Disparities and Improve Outcomes for Patients.

Journal: Transplantation and cellular therapy
Published: June 04, 2025

Understanding Diversity: An ASTCT-NMDP ACCESS Initiative Survey of the Hematopoietic Cell Transplant and Cellular Therapy Workforce in the United States.

Understanding Diversity: An ASTCT-NMDP ACCESS Initiative Survey of the Hematopoietic Cell Transplant and Cellular Therapy Workforce in the United States.

Journal: Transplantation and cellular therapy
Published: May 16, 2025

Cardiovascular disease-related mortality trends among adults with multiple myeloma in the United States from 1999 to 2023.

Cardiovascular disease-related mortality trends among adults with multiple myeloma in the United States from 1999 to 2023.

Journal: Leukemia research
Published: February 06, 2025

18F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation.

18F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation.

Journal: Radiology. Imaging cancer
Published: December 13, 2024

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in Jehovah's witness patients.

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in Jehovah's witness patients.

Journal: Leukemia research reports
Published: May 27, 2024

Impact of primary organ site of involvement by peripheral T-cell lymphoma not otherwise specified on survival.

Impact of primary organ site of involvement by peripheral T-cell lymphoma not otherwise specified on survival.

Journal: Cancer medicine
Published: June 19, 2023

Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies.

Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies.

Journal: Nature communications
Published: March 28, 2023

Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma.

Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia
Published: December 08, 2022
Showing 1-12 of 27

Last Updated: 09/26/2026